meglumine has been researched along with Cruveilhier-Baumgarten Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cauchy, F; De Vos, N; Rautou, PE; Ronot, M; Sartoris, R; Vilgrain, V | 1 |
| Feng, Q; Feng, YM; Guan, S; Li, SL; Wang, L; Zhang, CC; Zhao, JR; Zhao, XY; Zhu, Q | 1 |
2 other study(ies) available for meglumine and Cruveilhier-Baumgarten Syndrome
| Article | Year |
|---|---|
Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Gadobenate dimeglumine-enhanced magnetic resonance imaging can accurately predict the severity of esophageal varices and portal vein pressure in patients with hepatitis B cirrhosis.
Topics: Adult; Contrast Media; Esophageal and Gastric Varices; Female; Hepatitis B; Hepatitis B virus; Humans; Hypertension, Portal; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Portal Pressure; Portal Vein; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Risk Assessment; ROC Curve; Severity of Illness Index | 2020 |